Pear Therapeutics voluntarily files for Chapter 11
Pear Therapeutics, Inc. has announced that it and its subsidiary, Pear Therapeutics (US), Inc., have voluntarily filed for protection under chapter 11…
Pear Therapeutics, Inc. has announced that it and its subsidiary, Pear Therapeutics (US), Inc., have voluntarily filed for protection under chapter 11…
The document describes five expert proposals and a possible clinical-organizational process for the integration of Digital Therapeutics across depress…
BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines…
Moving menstrual health forward with iPhone and Apple Watch. Ahead of International Women’s Day, new preliminary findings from the Apple Women’s He…
Akili, a leading digital medicine company, has reported a 37% increase in EndeavorRxⓇ prescriptions in Q4 2022 over Q3 2022, and a 166% increase in FY…
With a shift towards greater patient involvement in healthcare across the world, there has been a rapid improvement in self-monitoring technology and …
Complicated pregnancies often require hospital admission, which can be stressful and inconvenient for expectant mothers. Telemonitoring, the remote mo…
Health and life sciences companies are facing the challenge of engaging digitally savvy healthcare professionals, patients, and stakeholders as techno…
A significant recognition of the groundbreaking approach of the Digital Medicines and Digital Therapeutic company PRESS RELEASE | Italy, Salerno, F…
Leveraging its global platform, Frontiers Health opens its stage to up-and-coming companies during the iconic Start-Up Discovery Sessions. This tim…